FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental ANDA for balsalazide disodium by Apotex Corp., clearing regulatory authorization for this generic ulcerative colitis medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BALSALAZIDE DISODIUM (balsalazide disodium)

Snippet

SUPPL AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)